Consolidation, cooperation, and planning for the worst are three strategies to consider implementing in light of economic uncertainties facing physicians.
MGMA’s 100th-anniversary conference runs Sept. 27-30 in San Antonio, and these 10 sessions put physician contracts, compensation and legal exposure on the table.
Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients